FRANCE-HEALTH-WOMEN-CONTRACEPTION : ニュース写真

FRANCE-HEALTH-WOMEN-CONTRACEPTION

クレジット: 
MARTIN BUREAU / スタッフ
Dominique Maraninchi (L), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) arrives for a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
キャプション:
Dominique Maraninchi (L), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) arrives for a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
お見積りショッピングカートを表示
作成日:
2013年01月30日(水)
報道写真番号:
160367865
リリース情報:
リリースされていません。詳細情報
制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスまでお問い合わせください。報道、編集用途の全権利保有: 英国、米国、アイルランド、イタリア、スペイン、カナダ(ケベックを除く)。その他の国での報道、編集用途の制限付きの権利については、電話にてお問い合わせください。
ライセンスタイプ:
ライツマネージライツマネージ製品のライセンスには、サイズ、配置、使用期間、配布地域における制限など、使用上の制限があります。 製品をご利用の際には、使用権を付与し、その用途に基づいた価格を明確にするために必要な情報を入力するよう求められます。
コレクション:
AFP
クレジット:
AFP/Getty Images
最大ファイルサイズ:
4,928 x 3,280 px (173.85 x 115.71 cm) - 72 dpi - 3.95MB
ソース:
AFP
バーコード:
AFP
オブジェクト名:
Par7459324

キーワード

このイメージは著作権の対象です。 ゲッティ イメージズは、このイメージまたはクリップの不正使用者を追及する権利、および著作権違反の損害賠償を請求する権利を有します。 このイメージの入手可能性は、購入するまで保証されません(削除されたり、価格が変わったりする場合があります)。
Dominique Maraninchi head of France's regulator the National Agency... ニュース写真 160367865Diane,パリ,フランス,ヘッド,到着,医療とヘルスケア,横長,記者会見,錠剤Photographer Collection: AFP 2013 AFPDominique Maraninchi (L), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) arrives for a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)